-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Stem Cell Therapy for Metabolic Syndrome and Endothelial Dysfunction
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Stem Cell Therapy for Metabolic Syndrome and Endothelial Dysfunction Drug Details Stem cell therapy...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Lomecel-B
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Lomecel-B Drug Details Lomecel-B is under development for the treatment of ageing frailty, hypoplastic...
-
Product Insights
Alzheimer’s Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Alzheimer’s Disease Drugs Development Report Overview Alzheimer's disease is a progressive, degenerative condition causing damage to memory and behavior due to the attack on the neurons. Predisposing factors include age, heredity, cardiovascular diseases or diabetes, and environmental factors. Symptoms include depression, anxiety, social withdrawal, irritability, and aggressiveness. Buy the Full Report for More Insights on the Alzheimer’s Disease Drugs in Development Report, Download a Free Sample The Alzheimer’s Disease Drugs in Development market research report provides an overview of the...
-
Product Insights
Alzheimer’s Disease Global Clinical Trials Review, H1, 2017
GlobalData's clinical trial report, “Alzheimer's Disease Global Clinical Trials Review, H1, 2017" provides an overview of Alzheimer's Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Alzheimer's Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Sector Analysis
Brazil Nephrology and Urology Devices Market Outlook to 2025 – Renal Dialysis Equipment
GlobalData’s “Brazil Nephrology and Urology Devices Market Outlook to 2025” is a comprehensive databook report, covering key market data on the Brazil Nephrology and Urology Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments – Renal Dialysis Equipment. The Brazil Nephrology and Urology Devices Market report provides key information and data on: • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is...